A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ

Dulce Maroni, Sandeep Rana, Chandrani Mukhopadhyay, Amarnath Natarajan, Mayumi Naramura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Activation of the NF-κB pathway is causally linked to initiation and progression of diverse cancers. Therefore, IKKβ, the key regulatory kinase of the canonical NF-κB pathway, should be a logical target for cancer treatment. However, existing IKKβ inhibitors are known to induce paradoxical immune activation, which limits their clinical usefulness. Recently, we identified a quinoxaline urea analog 13-197 as a novel IKKβ inhibitor that delays tumor growth without significant adverse effects in xenograft tumor models. In the present study, we found that 13-197 had little effect on LPS-induced NF-κB target gene induction by primary mouse macrophages while maintaining considerable anti-proliferative activities. These characteristics may explain absence of inflammatory side effects in animals treated with 13-197. Our data also demonstrate that the inflammation and proliferation-related functions of IKKβ can be uncoupled, and highlight the utility of 13-197 to dissect these downstream pathways.

Original languageEnglish (US)
Pages (from-to)319-324
Number of pages6
JournalImmunology Letters
Volume168
Issue number2
DOIs
StatePublished - Dec 1 2015

Fingerprint

Quinoxalines
Urea
Neoplasms
Heterografts
Phosphotransferases
Macrophages
Inflammation
Growth
Genes

Keywords

  • Bone marrow-derived macrophages
  • IKKβ inhibitor
  • Inflammatory cytokines
  • LPS
  • NF-κB

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ. / Maroni, Dulce; Rana, Sandeep; Mukhopadhyay, Chandrani; Natarajan, Amarnath; Naramura, Mayumi.

In: Immunology Letters, Vol. 168, No. 2, 01.12.2015, p. 319-324.

Research output: Contribution to journalArticle

Maroni, Dulce ; Rana, Sandeep ; Mukhopadhyay, Chandrani ; Natarajan, Amarnath ; Naramura, Mayumi. / A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ. In: Immunology Letters. 2015 ; Vol. 168, No. 2. pp. 319-324.
@article{22fdfcd445304d4b8dbc083e8135b7a1,
title = "A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ",
abstract = "Activation of the NF-κB pathway is causally linked to initiation and progression of diverse cancers. Therefore, IKKβ, the key regulatory kinase of the canonical NF-κB pathway, should be a logical target for cancer treatment. However, existing IKKβ inhibitors are known to induce paradoxical immune activation, which limits their clinical usefulness. Recently, we identified a quinoxaline urea analog 13-197 as a novel IKKβ inhibitor that delays tumor growth without significant adverse effects in xenograft tumor models. In the present study, we found that 13-197 had little effect on LPS-induced NF-κB target gene induction by primary mouse macrophages while maintaining considerable anti-proliferative activities. These characteristics may explain absence of inflammatory side effects in animals treated with 13-197. Our data also demonstrate that the inflammation and proliferation-related functions of IKKβ can be uncoupled, and highlight the utility of 13-197 to dissect these downstream pathways.",
keywords = "Bone marrow-derived macrophages, IKKβ inhibitor, Inflammatory cytokines, LPS, NF-κB",
author = "Dulce Maroni and Sandeep Rana and Chandrani Mukhopadhyay and Amarnath Natarajan and Mayumi Naramura",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.imlet.2015.10.011",
language = "English (US)",
volume = "168",
pages = "319--324",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ

AU - Maroni, Dulce

AU - Rana, Sandeep

AU - Mukhopadhyay, Chandrani

AU - Natarajan, Amarnath

AU - Naramura, Mayumi

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Activation of the NF-κB pathway is causally linked to initiation and progression of diverse cancers. Therefore, IKKβ, the key regulatory kinase of the canonical NF-κB pathway, should be a logical target for cancer treatment. However, existing IKKβ inhibitors are known to induce paradoxical immune activation, which limits their clinical usefulness. Recently, we identified a quinoxaline urea analog 13-197 as a novel IKKβ inhibitor that delays tumor growth without significant adverse effects in xenograft tumor models. In the present study, we found that 13-197 had little effect on LPS-induced NF-κB target gene induction by primary mouse macrophages while maintaining considerable anti-proliferative activities. These characteristics may explain absence of inflammatory side effects in animals treated with 13-197. Our data also demonstrate that the inflammation and proliferation-related functions of IKKβ can be uncoupled, and highlight the utility of 13-197 to dissect these downstream pathways.

AB - Activation of the NF-κB pathway is causally linked to initiation and progression of diverse cancers. Therefore, IKKβ, the key regulatory kinase of the canonical NF-κB pathway, should be a logical target for cancer treatment. However, existing IKKβ inhibitors are known to induce paradoxical immune activation, which limits their clinical usefulness. Recently, we identified a quinoxaline urea analog 13-197 as a novel IKKβ inhibitor that delays tumor growth without significant adverse effects in xenograft tumor models. In the present study, we found that 13-197 had little effect on LPS-induced NF-κB target gene induction by primary mouse macrophages while maintaining considerable anti-proliferative activities. These characteristics may explain absence of inflammatory side effects in animals treated with 13-197. Our data also demonstrate that the inflammation and proliferation-related functions of IKKβ can be uncoupled, and highlight the utility of 13-197 to dissect these downstream pathways.

KW - Bone marrow-derived macrophages

KW - IKKβ inhibitor

KW - Inflammatory cytokines

KW - LPS

KW - NF-κB

UR - http://www.scopus.com/inward/record.url?scp=84949549814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949549814&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2015.10.011

DO - 10.1016/j.imlet.2015.10.011

M3 - Article

VL - 168

SP - 319

EP - 324

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 2

ER -